134 related articles for article (PubMed ID: 8348710)
1. Effects of growth hormone therapy on the developmental changes of follicle stimulating hormone and insulin-like growth factor-I serum concentrations in Turner's syndrome.
Bourguignon JP; Gérard A; Deby-Dupont G; Franchimont P
Clin Endocrinol (Oxf); 1993 Jul; 39(1):85-9. PubMed ID: 8348710
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
[TBL] [Abstract][Full Text] [Related]
3. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
5. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
[TBL] [Abstract][Full Text] [Related]
7. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
[TBL] [Abstract][Full Text] [Related]
8. IGF-I resistance and Turner's syndrome.
Lebl J; Průhová S; Zapletalová J; Pechová M
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):37-41. PubMed ID: 11220703
[TBL] [Abstract][Full Text] [Related]
9. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
Hochberg Z; Aviram M; Rubin D; Pollack S
Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
[TBL] [Abstract][Full Text] [Related]
10. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
11. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
12. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
13. Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation.
Zadik Z; Landau H; Chen M; Altman Y; Lieberman E
J Clin Endocrinol Metab; 1992 Aug; 75(2):412-6. PubMed ID: 1386373
[TBL] [Abstract][Full Text] [Related]
14. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
[TBL] [Abstract][Full Text] [Related]
15. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome.
Simmons KE
Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256
[TBL] [Abstract][Full Text] [Related]
18. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.
Ranke MB; Blum WF; Haug F; Rosendahl W; Attanasio A; Enders H; Gupta D; Bierich JR
Acta Endocrinol (Copenh); 1987 Nov; 116(3):305-13. PubMed ID: 3687318
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
